tirzepatide cardiovascular outcomes trial 2024 Comparison of and dulaglutide on major adverse events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Evidence that tirzepatide protects against

Insulin secretion is a signal to cells to mop up excess glucose from the bloodstream

Nature Reviews Endocrinology / PMC, 2024

Understanding when to inject Tirzepatide is crucial for those considering this treatment option or already using it

For clients for whom Mounjaro (Tirzepatide) may not be suitable or accessible, Contour Medical Spa offers a variety of other weight management options and alternative prescription medications

Contrasting Tirzepatide with other GLP-1 agonists and considering its combinatory usage with other diabetes medications are two critical areas

Very easy to navigate instructions Im a new client with TIRZEPATIDE